Company Filing History:
Years Active: 2013
Title: Tatjana Sumanovac Ramljak: Innovator in Tumor Treatment
Introduction
Tatjana Sumanovac Ramljak is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for tumor treatment. Her innovative work has the potential to impact cancer therapies significantly.
Latest Patents
Tatjana holds a patent for "Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor." This invention relates to adamantane diaza-crown ether derivatives and their application in treating tumors. The compounds were synthesized through the reaction of adamantane-derived tosylates or adamantane acid chlorides with mono- and diaza-18-crown-6. The resulting compounds demonstrated varying degrees of antiproliferative and cytotoxic activity on several tumor cell lines, indicating their potential for inhibiting tumor growth.
Career Highlights
Tatjana is affiliated with the Ruđer Bošković Institute, where she conducts her research. Her work has garnered attention for its innovative approach to cancer treatment, showcasing her dedication to advancing medical science.
Collaborations
Tatjana collaborates with notable colleagues, including Marijeta Kralj and Kata Majerski. Their combined expertise contributes to the success of their research endeavors.
Conclusion
Tatjana Sumanovac Ramljak is a trailblazer in the field of tumor treatment, with her patented innovations paving the way for future advancements in cancer therapies. Her contributions to medicinal chemistry are invaluable and highlight the importance of research in improving health outcomes.